How AI Could Prevent the Development of New Illicit Drugs

Deep learning tools like DarkNPS aim to get governments and forensic labs ahead of novel designer drugs by predicting plausible new chemical formulas before they appear in the market. DarkNPS is trained on the HighResNPS database and outputs millions of potential compounds derived from altering known designer drugs. The article explains that this could speed identification when mass spectrometry lacks reference material, since DarkNPS can supply likely targets for comparison and could reduce turnaround times from months to minutes. The article also covers tradeoffs and limitations: predictions may be weakest when drugs evolve through large chemical changes, and the algorithm provides no direct information about physiological or psychological effects. There is additional debate about whether proactive drug bans reduce overdose harms and whether class-wide criminalization can slow research into substances with potential medical uses.